How does the lactic acid bacterial strain CCFM1116 support the immune system and modulate inflammation?
Views : 16
Update time : 2026-07-08 09:26:09
Lactobacillus fermentum CCFM1116 naturally produces CLA and CLnA through biotransformation, supported by a national invention patent. This in-situ generation of highly active conjugated fatty acids helps support immune health and modulate inflammatory responses. Combined with its prebiotic properties and advanced 5-layer microencapsulation technology, CCFM1116 is designed to survive gastrointestinal transit and colonize in the gut. This helps maintain microecological balance and provides targeted support for immune function and inflammation management.
This capability is rooted in its natural synthesis of conjugated fatty acids. Scientific research indicates that CLA and CLnA are valuable bioactive compounds that help support immune function and modulate inflammatory pathways. Acting as a natural biological factory, L. fermentum CCFM1116 continuously converts and releases these beneficial fatty acids in the gut, providing scientific support for metabolic health and intestinal barrier function.
Furthermore, advanced delivery technology and flexible business models provide strong support for product development. The 5-layer microencapsulation technology helps protect the strain from gastric acid and bile salts, helping to ensure that the active strain reaches the intestines effectively. In addition to its probiotic benefits, it also offers prebiotic properties to support gut microecology. We also provide comprehensive OEM customization services, helping brand owners leverage this patented ingredient—which combines probiotics, prebiotics, and active metabolites—to create highly competitive, customized health products.
This capability is rooted in its natural synthesis of conjugated fatty acids. Scientific research indicates that CLA and CLnA are valuable bioactive compounds that help support immune function and modulate inflammatory pathways. Acting as a natural biological factory, L. fermentum CCFM1116 continuously converts and releases these beneficial fatty acids in the gut, providing scientific support for metabolic health and intestinal barrier function.
Furthermore, advanced delivery technology and flexible business models provide strong support for product development. The 5-layer microencapsulation technology helps protect the strain from gastric acid and bile salts, helping to ensure that the active strain reaches the intestines effectively. In addition to its probiotic benefits, it also offers prebiotic properties to support gut microecology. We also provide comprehensive OEM customization services, helping brand owners leverage this patented ingredient—which combines probiotics, prebiotics, and active metabolites—to create highly competitive, customized health products.
